101 related articles for article (PubMed ID: 3089809)
1. Demonstration of neutrophil chemotactic activity in the sputum of cystic fibrosis patients with Pseudomonas aeruginosa infection.
Kharazmi A; Schiøtz PO; Høiby N; Baek L; Döring G
Eur J Clin Invest; 1986 Apr; 16(2):143-8. PubMed ID: 3089809
[TBL] [Abstract][Full Text] [Related]
2. Priming of neutrophils for enhanced oxidative burst by sputum from cystic fibrosis patients with Pseudomonas aeruginosa infection.
Kharazmi A; Rechnitzer C; Schiøtz PO; Jensen T; Baek L; Høiby N
Eur J Clin Invest; 1987 Jun; 17(3):256-61. PubMed ID: 3040421
[TBL] [Abstract][Full Text] [Related]
3. Pseudomonas aeruginosa alginate in cystic fibrosis sputum and the inflammatory response.
Pedersen SS; Kharazmi A; Espersen F; Høiby N
Infect Immun; 1990 Oct; 58(10):3363-8. PubMed ID: 2401567
[TBL] [Abstract][Full Text] [Related]
4. Chemotactic factors in bronchial secretions of cystic fibrosis patients.
Dayer Pastore F; Schlegel-Haueter SE; Belli DC; Rochat T; Dudez TS; Suter S
J Infect Dis; 1998 May; 177(5):1413-7. PubMed ID: 9593037
[TBL] [Abstract][Full Text] [Related]
5. Immune complexes in the sputum of patients with cystic fibrosis suffering from chronic Pseudomonas aeruginosa lung infection.
Schiøtz PO; Nielsen H; Høiby N; Glikmann G; Svehag SE
Acta Pathol Microbiol Scand C; 1978 Feb; 86(1):37-40. PubMed ID: 707104
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies in serum and sputum from patients with cystic fibrosis.
Schiøtz PO; Egeskjold EM; Høiby N; Permin H
Acta Pathol Microbiol Scand C; 1979 Oct; 87(5):319-24. PubMed ID: 117671
[TBL] [Abstract][Full Text] [Related]
7. Lipopolysaccharide (LPS), LPS-immune complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
Kronborg G
APMIS Suppl; 1995; 50():1-30. PubMed ID: 7756034
[TBL] [Abstract][Full Text] [Related]
8. Pseudomonas-infected cystic fibrosis patient sputum inhibits the bactericidal activity of normal human serum.
Schiller NL; Millard RL
Pediatr Res; 1983 Sep; 17(9):747-52. PubMed ID: 6413945
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory markers in cystic fibrosis patients with lung Pseudomonas aeruginosa infection.
Pukhalsky AL; Kapranov NI; Kalashnikova EA; Shmarina GV; Shabalova LA; Kokarovtseva SN; Pukhalskaya DA; Kashirskaja NJ; Simonova OI
Mediators Inflamm; 1999; 8(3):159-67. PubMed ID: 10704054
[TBL] [Abstract][Full Text] [Related]
10. Characterisation of the range of neutrophil stimulating mediators in cystic fibrosis sputum.
Mackerness KJ; Jenkins GR; Bush A; Jose PJ
Thorax; 2008 Jul; 63(7):614-20. PubMed ID: 18245144
[TBL] [Abstract][Full Text] [Related]
11. Activated complement in the sputum from patients with cystic fibrosis.
Schiøtz PO; Sørensen H; Høiby M
Acta Pathol Microbiol Scand C; 1979 Feb; 87C(1):1-5. PubMed ID: 433601
[TBL] [Abstract][Full Text] [Related]
12. Increased airway iron as a potential factor in the persistence of Pseudomonas aeruginosa infection in cystic fibrosis.
Reid DW; Carroll V; O'May C; Champion A; Kirov SM
Eur Respir J; 2007 Aug; 30(2):286-92. PubMed ID: 17504792
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of polymorphonuclear leukocyte chemotaxis by the mucoid exopolysaccharide of Pseudomonas aeruginosa.
Stiver HG; Zachidniak K; Speert DP
Clin Invest Med; 1988 Aug; 11(4):247-52. PubMed ID: 2971496
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Rhesus Theta-Defensin-1 in Experimental Models of Pseudomonas aeruginosa Lung Infection and Inflammation.
Bensman TJ; Jayne JG; Sun M; Kimura E; Meinert J; Wang JC; Schaal JB; Tran D; Rao AP; Akbari O; Selsted ME; Beringer PM
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559270
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a novel chemotactic factor for neutrophils in the bronchial secretions of patients with cystic fibrosis.
Dudez TS; Chanson M; Schlegel-Haueter SE; Suter S
J Infect Dis; 2002 Sep; 186(6):774-81. PubMed ID: 12198611
[TBL] [Abstract][Full Text] [Related]
16. Proteomic profile of cystic fibrosis sputum cells in adults chronically infected with
Pattison SH; Gibson DS; Johnston E; Peacock S; Rivera K; Tunney MM; Pappin DJ; Elborn JS
Eur Respir J; 2017 Jul; 50(1):. PubMed ID: 28679606
[TBL] [Abstract][Full Text] [Related]
17. Reduction in Pseudomonas aeruginosa sputum density during a cystic fibrosis pulmonary exacerbation does not predict clinical response.
Lam JC; Somayaji R; Surette MG; Rabin HR; Parkins MD
BMC Infect Dis; 2015 Mar; 15():145. PubMed ID: 25887462
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-8: an important chemoattractant in sputum of patients with chronic inflammatory airway diseases.
Richman-Eisenstat JB; Jorens PG; Hébert CA; Ueki I; Nadel JA
Am J Physiol; 1993 Apr; 264(4 Pt 1):L413-8. PubMed ID: 8476069
[TBL] [Abstract][Full Text] [Related]
19. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients.
Bjarnsholt T; Jensen PØ; Fiandaca MJ; Pedersen J; Hansen CR; Andersen CB; Pressler T; Givskov M; Høiby N
Pediatr Pulmonol; 2009 Jun; 44(6):547-58. PubMed ID: 19418571
[TBL] [Abstract][Full Text] [Related]
20. Harnessing Neutrophil Survival Mechanisms during Chronic Infection by
Marteyn BS; Burgel PR; Meijer L; Witko-Sarsat V
Front Cell Infect Microbiol; 2017; 7():243. PubMed ID: 28713772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
